Composition Comprising a Mixture of Dextro -And Levo-Amphetamines Complexed with Ion-Exchange Resin Particles to Form Drug Resin Particles
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application PCT/US2012/044698, filed Jun 28, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,709,491 | Composition Comprising a Mixture of Dextro- and Levo- Amphetamines Complexed with Ion-Exchange Resin Particles to Form Drug Resin Particles In force · High confidence UsedRemaining | Neos Therapeutics, LP | In force | High confidence | ||
| US 9,017,731 | Composition Comprising a Mixture of Dextro -And Levo-Amphetamines Complexed with Ion-Exchange Resin Particles to Form Drug Resin Particles In force · High confidence | Neos Therapeutics, LP | In force | High confidence | ||
| US 9,072,680 | Compositions Comprising Methylphenidate Complexed with Ion-Exchange Resin Particles In force · High confidence | Neos Therapeutics, LP | In force | High confidence | ||
| US 9,089,496 | Compositions Comprising Methylphenidate Complexed with Ion-Exchange Resin Particles In force · High confidence | Neos Therapeutics, LP | In force | High confidence | ||
| US 9,265,737 | Pharmaceutical Composition Comprising Amphetamines Complexed with Ion-Exchange Resin Particles In force · High confidence | Neos Therapeutics, LP | In force | High confidence | ||
| US 9,839,619 | Method for Treating Add or Adhd Comprising Administering Amphetamine Complexed with Ion-Exchange Resin Particles In force · High confidence | Neos Therapeutics LP | In force | High confidence | ||
| Application 13/844,510 | Method for reducing the effects of an elevated exposure to methyphenidate in presence of ethanol by using a composition comprising methylphenidate complexed with ion-exchange resin particles Abandoned Abandoned Aug 17, 2020 | Neos Therapeutics LP | Abandoned | Abandoned Aug 17, 2020 | ||
| Application 13/844,628 | Dosage Forms for Oral Administration and Methods of Treatment Using the Same Abandoned Abandoned Oct 28, 2019 | Neos Therapeutics, LP | Abandoned | Abandoned Oct 28, 2019 | ||
| Application 13/947,861 | Treating Add or Adhd with a Composition Comprising Methylphenidate Complexed with Ion-Exchange Resin Particles Abandoned Abandoned Aug 17, 2020 | Neos Therapeutics, LP | Abandoned | Abandoned Aug 17, 2020 | ||
| Application 13/947,897 | Dosage Forms for Oral Administration and Methods of Treatment Using the Same Abandoned Abandoned Jun 28, 2019 | Neos Therapeutics, LP | Abandoned | Abandoned Jun 28, 2019 |
10 of 10 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Neos Therapeutics, LP.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.